Targeting the transcription factor receptor LXR to treat clear cell renal cell carcinoma: agonist or inverse agonist?

Growing evidence indicates that clear cell renal cell carcinoma (ccRCC) is a metabolism-related disease. Changes in fatty acid (FA) and cholesterol metabolism play important roles in ccRCC development. As a nuclear transcription factor receptor, Liver X receptor (LXR) regulates a variety of key mole...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Cell Death Dis
Huvudupphovsmän: Wu, Guangzhen, Wang, Qinglian, Xu, Yingkun, Li, Jianyi, Zhang, Hongge, Qi, Guanghui, Xia, Qinghua
Materialtyp: Artigo
Språk:Inglês
Publicerad: Nature Publishing Group UK 2019
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6538631/
https://ncbi.nlm.nih.gov/pubmed/31138790
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41419-019-1654-6
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk